Vaccination protects against new emerging PRRS strain
Ingelvac PRRS® MLV provides cross-protection against a PRRSv 1-7-4 challenge.
14 February 2019
4 minute read
| References | ||||
|---|---|---|---|---|
| 1 Patterson A, Victoria J, Jordan D, et al. | ||||
| (2013) | Modified-live PRRS vaccination is efficacious following challenge with eight genetically diverse PRRSv isolates, in Proceedings. | |||
| 2 Patterson A, Haiwick G, Hermann J, et al. | ||||
| (2017) | Efficacy of Ingelvac PRRS® MLV against a heterologous PRRSv 1-7-4 RFLP challenge. | |||
